Status:
COMPLETED
Efficacy of Milrinone With Sildenafil in Persistent Pulmonary Hypertension in Children
Lead Sponsor:
Muhammad Aamir Latif
Conditions:
Persistent Pulmonary Hypertension of the Newborn
Eligibility:
All Genders
1-28 years
Phase:
NA
Brief Summary
Neonates with persistent pulmonary hypertension (PPH) should be administered inhaled nitric oxide (iNO) and extracorporeal membrane oxygenation (ECMO), but these are not available in most resource-con...
Eligibility Criteria
Inclusion
- Patients of either gender
- Aged between 1-28 days
- Birth weight above 2000 grams
- Diagnosed with persistent pulmonary hypertension (as per echocardiography)
Exclusion
- Neonates having congenital heart defects (CHDs)
- Congenital diaphragmatic hernia
- Lung anomalies
- History of any surgical intervention
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2024
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT06562036
Start Date
December 1 2023
End Date
May 31 2024
Last Update
August 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital and institute of Child Health
Multan, Punjab Province, Pakistan, 60000